Enliven Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	119.44	124.12	100.14	75.54	110.02	130.37
Short-Term Investments	371.07	189.32	153.01	-	-	-
Cash & Short-Term Investments	490.5	313.44	253.15	75.54	110.02	130.37
Cash Growth	57.02%	23.82%	235.14%	-31.35%	-15.60%	-
Prepaid Expenses	5.12	4.63	2.95	2.22	0.65	0.06
Restricted Cash	-	0.05	0.05	-	-	0.05
Other Current Assets	-	-	10	-	-	0.1
Total Current Assets	495.62	318.13	266.15	77.75	110.67	130.59
Property, Plant & Equipment	1.03	0.46	1.06	1.52	0.95	0.42
Long-Term Deferred Charges	-	-	0.56	3.98	1.65	-
Other Long-Term Assets	7.24	7.18	4.09	0.05	0.05	-
Total Assets	503.89	325.76	271.87	83.3	113.33	131
Accounts Payable	2.35	1.34	0.53	3.44	2.52	0.81
Accrued Expenses	12.42	14.37	14.66	4.32	2.84	0.43
Current Portion of Leases	0.38	-	0.34	0.32	0.16	0.11
Other Current Liabilities	0.06	0.2	10.36	1.64	0.23	0.14
Total Current Liabilities	15.21	15.92	25.89	9.72	5.75	1.48
Long-Term Leases	0.2	-	-	0.28	-	-
Other Long-Term Liabilities	-	-	0.07	0.38	0.71	0.08
Total Liabilities	15.42	15.92	25.96	10.37	6.47	1.56
Common Stock	0.06	0.05	0.04	0	0	0
Additional Paid-In Capital	785.94	553.21	400.17	6.04	2.31	0.16
Retained Earnings	-297.35	-243.47	-154.45	-82.86	-45.2	-20.46
Comprehensive Income & Other	-0.18	0.06	0.14	-	-	-
Total Common Equity	488.47	309.85	245.91	-76.83	-42.89	-20.3
Shareholders' Equity	488.47	309.85	245.91	72.92	106.86	129.45
Total Liabilities & Equity	503.89	325.76	271.87	83.3	113.33	131
Total Debt	0.58	-	0.34	0.6	0.16	0.11
Net Cash (Debt)	489.92	313.44	252.81	74.94	109.87	130.26
Net Cash Growth	56.92%	23.98%	237.37%	-31.79%	-15.66%	-
Net Cash Per Share	9.78	6.66	7.11	23.99	14.06	26.12
Filing Date Shares Outstanding	59.24	49	41.35	12.1	11.64	4.99
Total Common Shares Outstanding	59.23	48.94	41.29	12.1	11.64	4.99
Working Capital	480.41	302.21	240.26	68.04	104.92	129.11
Book Value Per Share	8.25	6.33	5.96	-6.35	-3.68	-4.07
Tangible Book Value	488.47	309.85	245.91	-76.83	-42.89	-20.3
Tangible Book Value Per Share	8.25	6.33	5.96	-6.35	-3.68	-4.07
Machinery	1.54	1.38	1.41	1.26	0.65	0.46

Updated Aug 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q